Toggle sidebar
定价
登录
This Surging Biotech Stock Shrugs Off Positive Cancer Trial Results and Slips. What to Know.
Barrons
·
2026-05-11 20:26
公司临床试验进展 - Inhibrx Biosciences公司发布了其新型头颈癌治疗药物的试验初步结果 结果显示积极 [1]
This Surging Biotech Stock Shrugs Off Positive Cancer Trial Results and Slips. What to Know. - Reportify
